Safety Study of 89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors
Latest Information Update: 07 Mar 2023
At a glance
- Drugs Envafolimab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 07 Mar 2023 New trial record